Responding to COVID-19
Our COVID-19 member resources provide the latest clinical, surgical and pharmacy supply updates, including information from the Vizient Disaster Response team.
View the latest COVID-19 updates
Member update
For Vizient Members only: our COVID-19 member resources provide the latest clinical, surgical and pharmacy supply updates.
Webinars
Vizient hosts COVID-19 webinars featuring our members and experts who lead their teams and facilities.
Tech Watch
Explore COVID-19 in the pediatric setting, lung protective technologies, innovative pediatric devices, novel pharmaceuticals and more.
Find solutions to your most pressing challenges
C-level leaders
Accelerate performance and improve operations and quality of care with powerful analytics for smarter, faster decision-making.
Clinical leaders
Improve quality, cost effectiveness and patient care with top clinical analytics and care team optimization solutions.
Supply chain leaders
Prioritize, track and measure supply chain operations to achieve intelligent, sustainable cost structure.
Pharmacy leaders
Transform your pharmacy into a strategic asset with solutions to safely and effectively manage drug distribution.
Visit your Member Dashboard
Vizient has created a new Member Dashboard to provide easier access to frequently used tools, reports and networks. Log in to see your dashboard – personalized with the tools, reports and other information you use regularly.
Easy access
Achieving more, together
Vizient combines the strengths of VHA, University HealthSystem Consortium, Novation and MedAssets’ Spend and Clinical Resource Management segment, including Sg2, to form the nation’s largest member-driven health care performance improvement company.
Learn more about our storyOur purpose is to ensure our members deliver exceptional, cost-effective care. We accomplish this by connecting them with the knowledge, solutions and expertise to achieve healthier outcomes.
News and insights
Understanding the Risks, Opportunities and Prospects of Biosimilars in 2020 and Beyond
Entering 2020, we have the opportunity to take a moment, look back and reflect on the lessons learned of the previous decade with regard to biosimilars. The road to a successful biosimilars market has been anything but straightforward.
View all member newslettersConnect with us to learn how we can help you achieve your health care improvement goals.